Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Aslan, Bausch Health, Biocryst, Bridge, Eli Lilly, Firstwave, Fujifilm, Kazia, Laurent, Mesoblast, Neuclone, Viriom.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Ansun, Apeiron, Cytodyn, Eusa, Hutchison China Meditech, I-Mab, Inflarx, Inovio, Kiniksa, Nanocarrier, Novan, Oncoceutics, Sato, Synairgen, Vanda, VBL.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Cytodyn, Genentech, Humanigen, Immutep, Inxmed (Shanghai) Co., Recce.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Moderna, Regeneron, Sanofi, Santen, Takeda, Tracon.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Bioarctic, Chugai, Cytodyn, Eisai, Innovent Biologics, Oncolys.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Eisai, Harbour Biomed, Immutep, Isofol Medical, Kowa Research Institute, Molecular Templates, Ribomic, Zelira.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Acucela, Astellas, Celltrion Healthcare, Kubota, Noxopharm, Pfizer, Seattle Genetics, Takeda, TLC Co.
RSS